What Lunit does
Lunit develops medical AI software for early cancer detection and precision oncology, combining medical image analysis with clinical intelligence. Its products help clinicians find cancer earlier and guide more precise treatment decisions, and the company operates across many countries and customer sites worldwide.
Key capabilities
The INSIGHT line provides AI analysis for cancer screening, including 2D mammography (MMG), 3D digital breast tomosynthesis (DBT), and chest X-ray (CXR), with companion tools for risk assessment, density evaluation, and quality management. The SCOPE line supports precision oncology with tumor microenvironment analysis, immunohistochemistry quantification such as HER2 and PD-L1, and genotype prediction from pathology images.
Who it's for
Lunit serves radiologists and imaging centers, oncologists and pathologists, hospital systems, and biopharma companies using AI for clinical trials and companion diagnostics.